Phase 1 Liver Transplant Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1
EVR and EPO for Liver Transplant Tolerance
Liver Transplant
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled3 locationsNCT06832189
Recruiting
Phase 1Phase 2
Immune Tolerance Induction After Liver Transplantation
Liver TransplantationEnd Stage Liver DiseaseImmune Tolerance+6 more
University of California, Los Angeles12 enrolled1 locationNCT07269041
Recruiting
Phase 1
A Study of SIPLIZUMAB in AILD and LT Patients
Autoimmune HepatitisPrimary Sclerosing CholangitisLiver Transplant Disorder+1 more
Elizabeth C. Verna8 enrolled1 locationNCT06455280
Recruiting
Phase 1Phase 2
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Liver CancerLiver MetastasesLiver Cirrhosis+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC90 enrolled1 locationNCT07053488
Recruiting
Phase 1Phase 2
Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
Hepatocellular Carcinoma (HCC)Liver Transplant SurgeryMacrovascular Invasion+1 more
University Health Network, Toronto48 enrolled2 locationsNCT06725121
Recruiting
Phase 1
Safety of DNP007 in Healthy Subjects
Liver Transplant; ComplicationsSteatohepatitis, NonalcoholicLiver Transplant Rejection
Seoul National University Hospital12 enrolled1 locationNCT06400771